Trends in opioid use among adults with cardiovascular disease, 2001 – March 2020
Journal of the American Pharmacists Association · 2026
DOI: 10.1016/j.japh.2025.102937 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Pharmacists Association, 2026. Verfasst von Gi Eun Han und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Analgesics, Opioid, Cardiovascular Diseases. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Opioids can cause adverse cardiovascular effects (e.g., hypotension, arrhythmias), which can be concerning in individuals with pre-existing cardiovascular disease (CVD). Currently, little is known regarding the trends in opioid use among individuals with CVD. OBJECTIVE: To evaluate the long-term trends of prescription opioids among adults with CVD in the United States. METHODS: Using National Health and Nutrition Examination Survey data from 2001 to March 2020, adults ≥20 year old with ≥1 of the following CVDs - heart failure, coronary heart disease, angina, myocardial infarction, and stroke - were identified. Trends in the use of any, short-term (≤90 days), and long-term (>90 days) prescription opioids were evaluated. Subgroup analyses were conducted to test trends in any prescription opioid use by CVD types, pain-related comorbidities, and demographic/socioeconomic characteristics. Multivariable logistic regression, adjusted for age, was used to test the trends in 4-year examination periods. RESULTS: Among 6250 participants with CVD, no significant trends in the use of any prescription opioids were observed throughout the study period (9.4% in 2001-2004% to 11.8% in 2017-March 2020; P = 0.25). The prevalence of long-term prescription opioid use increased from 6.6% in 2001-2004% to 10.4% in 2017-March 2020, with a peak prevalence of 12.6% in 2013-2016 (P = 0.04). During the study period, an increase in the prevalence of any prescription opioid use was seen among individuals aged ≥65 years, from 7.5% in 2001-2004% to 11.3% in 2017-March 2020 (P = 0.006). CONCLUSION: Although overall prescription opioid use among participants with CVD remained relatively consistent between 2001 and March 2020, the use of long-term opioid prescriptions increased, possibly reflecting a growing burden of chronic pain in this population. Prescription opioid use also appeared to have increased among individuals aged ≥65 years, raising concerns due to their heightened risk of cardiovascular adverse effects from opioids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Han, G. E., & Hwang, A. Y. (2026). Trends in opioid use among adults with cardiovascular disease, 2001 – March 2020. Journal of the American Pharmacists Association. https://doi.org/10.1016/j.japh.2025.102937
Vancouver
Han GE, Hwang AY. Trends in opioid use among adults with cardiovascular disease, 2001 – March 2020. Journal of the American Pharmacists Association. 2026. doi:10.1016/j.japh.2025.102937
BibTeX
@article{Han2026,
author = {Han, Gi Eun and Hwang, Andrew Y},
title = {Trends in opioid use among adults with cardiovascular disease, 2001 – March 2020},
journal = {Journal of the American Pharmacists Association},
year = {2026},
doi = {10.1016/j.japh.2025.102937}
}
EUVIMED